Northrop Grumman Q3 Earnings Up, B-21 Program Losses Mount

TL;DR

**NOC's Q3 looks good, but the B-21 program is a money pit; watch that $1.6B loss accrual, it's a red flag for future earnings.**

AI Summary

Northrop Grumman Corporation reported total sales of $10.423 billion for the three months ended September 30, 2025, an increase from $9.996 billion in the same period of 2024. Net earnings for the quarter rose to $1.100 billion, up from $1.026 billion year-over-year. However, for the nine months ended September 30, 2025, total sales slightly decreased to $30.242 billion from $30.347 billion in 2024, and net earnings declined to $2.755 billion from $2.910 billion. A significant event was the divestiture of the Immersive Mission Solutions (IMS) operating unit on May 24, 2025, for $333 million in cash, resulting in a pre-tax gain of $231 million. The company recognized an additional $477 million loss provision on the B-21 program in Q1 2025, bringing the total remaining loss accrual to $1.6 billion as of September 30, 2025. Backlog stood at $91.4 billion, with approximately 40% expected to be recognized as revenue over the next 12 months. Cash and cash equivalents decreased significantly to $1.957 billion as of September 30, 2025, from $4.353 billion at December 31, 2024, primarily due to $2.765 billion in net cash used in financing activities, including $1.168 billion in common stock repurchases and $964 million in cash dividends paid.

Why It Matters

Northrop Grumman's mixed financial results, with a strong Q3 but a nine-month decline in net earnings, signal a complex environment for investors. The $1.6 billion B-21 program loss accrual highlights significant execution risks in major defense contracts, potentially impacting future profitability and investor confidence. The divestiture of the training services business for $333 million indicates a strategic portfolio optimization, which could free up capital for core defense initiatives. For employees, the B-21 program's challenges could lead to increased scrutiny and pressure, while customers, particularly the U.S. government, will be closely watching the program's progress and cost overruns. Competitively, successful management of large-scale, complex programs like the B-21 is crucial for maintaining market leadership against rivals like Lockheed Martin and Boeing.

Risk Assessment

Risk Level: high — The company faces high risk due to the significant $1.6 billion remaining loss accrual on the B-21 program as of September 30, 2025, following an additional $477 million loss provision in Q1 2025. This indicates substantial cost overruns and execution challenges. Furthermore, net cash provided by operating activities decreased sharply to $860 million for the nine months ended September 30, 2025, from $1.810 billion in the prior year, signaling reduced operational cash generation.

Analyst Insight

Investors should closely monitor the B-21 program's progress and any further loss provisions, as it significantly impacts future profitability. Given the substantial cash outflow from financing activities, including $1.168 billion in stock repurchases, investors should assess if capital allocation is effectively balancing shareholder returns with mitigating program risks and strengthening operational cash flow.

Financial Highlights

debt To Equity

1.17

revenue

$10.423B

operating Margin

11.9%

total Assets

$49.300B

total Debt

$15.162B

net Income

$1.100B

eps

$7.67

gross Margin

25.4%

cash Position

$1.957B

revenue Growth

+4.3%

Revenue Breakdown

Key Numbers

• $10.423B — Total sales for Q3 2025 (Increased from $9.996B in Q3 2024)
• $1.100B — Net earnings for Q3 2025 (Increased from $1.026B in Q3 2024)
• $30.242B — Total sales for nine months ended Sept 30, 2025 (Decreased from $30.347B in 2024)
• $2.755B — Net earnings for nine months ended Sept 30, 2025 (Decreased from $2.910B in 2024)
• $477M — Additional B-21 program loss provision (Recognized in Q1 2025)
• $1.6B — Remaining B-21 program loss accrual (As of September 30, 2025)
• $333M — Cash from divestiture of training services business (Completed on May 24, 2025)
• $231M — Pre-tax gain on sale of training services business (Recorded from the divestiture)
• $91.4B — Company backlog (As of September 30, 2025, with a $150M reduction from divestiture)
• $1.957B — Cash and cash equivalents (As of September 30, 2025, down from $4.353B at Dec 31, 2024)

Key Players & Entities

• NORTHROP GRUMMAN CORP /DE/ (company) — registrant
• B-21 program (company) — major defense program with significant loss accruals
• Immersive Mission Solutions (IMS) (company) — operating unit divested by Northrop Grumman
• U.S. government (regulator) — customer for IMS and other defense programs
• FASB (regulator) — Financial Accounting Standards Board
• SEC (regulator) — Securities and Exchange Commission
• Lockheed Martin (company) — competitor
• Boeing (company) — competitor
• $1.6 billion (dollar_amount) — remaining loss accrual on the B-21 program
• $91.4 billion (dollar_amount) — company backlog as of September 30, 2025

FAQ

Risk Factors

• B-21 Program Loss Provision [high — operational]: The company recognized an additional $477 million loss provision on the B-21 program in Q1 2025, bringing the total remaining loss accrual to $1.6 billion as of September 30, 2025. This indicates significant cost overruns or performance issues on a key program.
• Decreased Cash Position [medium — financial]: Cash and cash equivalents decreased significantly to $1.957 billion as of September 30, 2025, from $4.353 billion at December 31, 2024. This was primarily due to $2.765 billion in net cash used in financing activities, including substantial share repurchases and dividends.
• Backlog Concentration [medium — market]: The company has a substantial backlog of $91.4 billion. While this provides revenue visibility, approximately 40% is expected to be recognized over the next 12 months, implying a significant portion of future revenue is tied to longer-term contracts and program execution.
• Government Contract Compliance [medium — regulatory]: As a major defense contractor, Northrop Grumman is subject to stringent government regulations and oversight. Non-compliance or changes in government procurement policies could impact contract awards and profitability.
• Long-Term Debt Levels [medium — financial]: Long-term debt stands at $15.162 billion as of September 30, 2025. While manageable given the company's scale, significant debt levels require consistent cash flow generation to service interest payments and principal repayments.

Industry Context

Northrop Grumman operates in the highly competitive aerospace and defense industry, characterized by long-term government contracts and significant R&D investments. Key trends include increasing defense spending globally, technological advancements in areas like AI and cybersecurity, and consolidation among major players. The company faces competition from other large defense contractors and emerging technology firms.

Regulatory Implications

As a primary contractor for the U.S. government, Northrop Grumman is subject to extensive regulatory oversight, including compliance with procurement regulations, export controls, and cybersecurity standards. Changes in government spending priorities or stricter compliance requirements could impact future revenue and profitability.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-05-24: Divestiture of Immersive Mission Solutions (IMS) — Generated $333 million in cash and a $231 million pre-tax gain, streamlining the company's portfolio.
• 2025-09-30: End of Q3 2025 — Reported $10.423 billion in sales and $1.100 billion in net earnings for the quarter, showing sequential growth.
• 2025-09-30: End of Nine Months 2025 — Total sales slightly decreased to $30.242 billion, and net earnings declined to $2.755 billion year-over-year, impacted by program charges.
• 2025-01-01: Start of Fiscal Year 2025 — The company recognized an additional $477 million loss provision on the B-21 program during the first quarter.

Glossary

Inventoried Costs, Net

Represents the costs associated with goods that have been manufactured but not yet sold or shipped to customers. (An increase from $1.455B to $1.615B suggests higher production levels or longer production cycles for certain products.)

Unbilled Receivables, Net

Revenue that has been earned but not yet billed to customers, typically under long-term contracts where billing is milestone-based. (A significant increase from $5.908B to $7.030B indicates a growing amount of earned revenue not yet invoiced, potentially due to contract progress.)

Advance Payments and Billings in Excess of Costs Incurred

Represents amounts received from customers in advance of work performed or amounts billed to customers that exceed the costs incurred to date. (A decrease from $4.070B to $3.562B suggests a reduction in customer prepayments or a faster rate of cost incurrence relative to billings.)

Operating Lease Right-of-Use Assets

Assets recognized under accounting standards for leases, representing the right to use an asset over the lease term. (Relatively stable at $1.783B, indicating consistent use of leased facilities and equipment.)

Goodwill

An intangible asset representing the excess of the purchase price of an acquired company over the fair value of its identifiable net assets. (A slight decrease from $17.512B to $17.436B suggests minor adjustments or amortization related to past acquisitions.)

Deferred Tax Assets

Tax assets that arise from temporary differences between accounting income and taxable income, or from tax loss carryforwards. (A decrease from $1.599B to $1.255B may indicate utilization of these assets or changes in future taxable income expectations.)

Pension and Other Postretirement Benefit Plan Assets

Assets set aside to fund future pension and postretirement benefit obligations. (An increase from $2.184B to $2.501B suggests favorable investment returns or contributions to the plans.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, total sales for Northrop Grumman have slightly decreased from $30.347 billion to $30.242 billion, and net earnings have declined from $2.910 billion to $2.755 billion. This decline is partly attributed to the significant $477 million loss provision recognized on the B-21 program in Q1 2025. While Q3 2025 showed year-over-year growth in both sales and net earnings, the year-to-date figures reflect ongoing program challenges and a shift in financial performance.

Filing Documents

• noc-20250930.htm (10-Q) — 1768KB
• noc-09302025xex15.htm (EX-15) — 4KB
• noc-09302025xex311.htm (EX-31.1) — 10KB
• noc-09302025xex312.htm (EX-31.2) — 10KB
• noc-09302025xex321.htm (EX-32.1) — 5KB
• noc-09302025xex322.htm (EX-32.2) — 5KB
• 0001133421-25-000053.txt ( ) — 8818KB
• noc-20250930.xsd (EX-101.SCH) — 47KB
• noc-20250930_cal.xml (EX-101.CAL) — 47KB
• noc-20250930_def.xml (EX-101.DEF) — 230KB
• noc-20250930_lab.xml (EX-101.LAB) — 630KB
• noc-20250930_pre.xml (EX-101.PRE) — 436KB
• noc-20250930_htm.xml (XML) — 1742KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) Condensed Consolidated Statements of Earnings and Comprehensive Income 1 Condensed Consolidated Statements of Financial Position 2 Condensed Consolidated Statements of Cash Flows 3 Condensed Consolidated Statements of Changes in Shareholders' Equity 4 Notes to Condensed Consolidated Financial Statements 1. Summary of Significant Accounting Policies 5 2. Earnings Per Share, Share Repurchases and Dividends on Common Stock 7 3. Inventoried Costs, Net 9 4. Income Taxes 9 5. Fair Value of Financial Instruments 10 6. Investigations, Claims and Litigation 11 7. Commitments and Contingencies 12 8. Retirement Benefits 13 9. Stock Compensation Plans and Other Compensation Arrangements 14 10. Segment Information 15 Report of Independent Registered Public Accounting Firm 21

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Overview 22 Consolidated Operating Results 25 Segment Operating Results 27 Product and Service Analysis 32 Backlog 33 Liquidity and Capital Resources 33 Critical Accounting Policies, Estimates and Judgments 35 Accounting Standards Updates 35

Forward-Looking Statements and Projections

Forward-Looking Statements and Projections 35

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 36

Controls and Procedures

Item 4. Controls and Procedures 37

– OTHER INFORMATION

PART II – OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 38

Risk Factors

Item 1A. Risk Factors 38

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Other Information

Item 5. Other Information 39

Exhibits

Item 6. Exhibits 40

Signatures

Signatures 41 i Table of Contents NORTHROP GRUMMAN CORPORATION

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME (Unaudited) Three Months Ended September 30 Nine Months Ended September 30 $ in millions, except per share amounts 2025 2024 2025 2024 Sales Product $ 8,369 $ 7,939 $ 24,148 $ 24,117 Service 2,054 2,057 6,094 6,230 Total sales 10,423 9,996 30,242 30,347 Operating costs and expenses Product 6,631 6,280 19,523 19,079 Service 1,565 1,610 4,702 4,838 General and administrative expenses 985 986 3,008 3,149 Total operating costs and expenses 9,181 8,876 27,233 27,066 Gain on sale of business — — 231 — Operating income 1,242 1,120 3,240 3,281 Other (expense) income Interest expense ( 161 ) ( 161 ) ( 490 ) ( 461 ) Non-operating FAS pension benefit 136 168 403 503 Other, net 106 61 175 142 Earnings before income taxes 1,323 1,188 3,328 3,465 Federal and foreign income tax expense 223 162 573 555 Net earnings $ 1,100 $ 1,026 $ 2,755 $ 2,910 Basic earnings per share $ 7.69 $ 7.02 $ 19.16 $ 19.73 Weighted-average common shares outstanding, in millions 143.1 146.2 143.8 147.5 Diluted earnings per share $ 7.67 $ 7.00 $ 19.12 $ 19.69 Weighted-average diluted shares outstanding, in millions 143.5 146.5 144.1 147.8 Net earnings (from above) $ 1,100 $ 1,026 $ 2,755 $ 2,910 Other comprehensive income (loss), net of tax Change in cumulative translation adjustment 2 2 11 2 Change in other, net ( 1 ) 8 18 ( 10 ) Other comprehensive income (loss), net of tax 1 10 29 ( 8 ) Comprehensive income $ 1,101 $ 1,036 $ 2,784 $ 2,902 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. -1- Table of Contents NORTHROP GRUMMAN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) $ in millions, except par value September 30, 2025 December 31, 2024 Assets Cash and cash equivalents $ 1,957 $ 4,353 Accounts receivable, net 1,983 1,272 Unbilled receivables, net 7,030 5,908 Inv